Restless legs syndrome

American Family Physician

Volumn 78, Issue 2, 2008, Pages

  Bayard, Max ^a,b   Avonda, Thomas ^a   Wadzinski, James ^a  

^a East Tennessee State University   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; CABERGOLINE; CAFFEINE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; DEXTROPROPOXYPHENE; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; IRON; LITHIUM; NEUROLEPTIC AGENT; OPIATE; OXYCODONE; PERGOLIDE; PERGOLIDE MESILATE; PLACEBO; PRAMIPEXOLE; ROPINIROLE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; ZOLPIDEM; ZOLPIDEM TARTRATE;

AKATHISIA; ANXIETY; CLINICAL EVALUATION; CLINICAL TRIAL; CONSTIPATION; DAYTIME SOMNOLENCE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DEPENDENCE; DRUG DOSE INCREASE; DRUG USE; FALLING; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; KIDNEY FAILURE; LEG CRAMP; LEG MOVEMENT; LIFESTYLE MODIFICATION; MOTOR DYSFUNCTION; NAUSEA; NEUROLOGIC DISEASE; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; PREGNANCY; PROGNOSIS; QUALITY OF LIFE; REST; RESTLESS LEGS SYNDROME; REVIEW; SEDATION; SIDE EFFECT; SLEEP DISORDER; VALVULAR HEART DISEASE; ARTICLE; KINESIOTHERAPY;

CLINICAL TRIALS AS TOPIC; DOPAMINE AGONISTS; EXERCISE THERAPY; HUMANS; RESTLESS LEGS SYNDROME;

EID: 50349088514     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160(14):2137-2141. (Pubitemid 30482720)
2. Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest. 2006;129(1):76-80.
3. Hening W, Walters AS, Allen RP, Montplaisir J, Myers A, Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004;5(3):237-246. (Pubitemid 38684217)
4. Garcia-Borreguero D, Larrosa O, Granizo JJ, de la Llave Y, Hening WA. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep. 2004;27(4):669-673. (Pubitemid 38823363)
5. Earley CJ, Hyland K, Allen RP. Circadian changes in CSF dopaminergic measures in restless legs syndrome. Sleep Med. 2006;7(3):263-268.
6. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56(2):263-265. (Pubitemid 32095374)
7. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54(8):1698-1700. (Pubitemid 30226823)
8. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep. 1998;21(4):371-377. (Pubitemid 128470320)
9. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23(3):200-203. (Pubitemid 24158288)
10. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, for the International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101-119.
11. Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry. 2004;75(2):226-230. (Pubitemid 38183528)
12. Poewe W, Högl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology. 2004;63(8 suppl 3):S12-S16. (Pubitemid 39426253)
13. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121-132. (Pubitemid 36527232)
14. Silber MH, Ehrenberg BL, Allen RP, et al., for the Medical Advisory Board of the Restless Legs Syndrome Foundation. An algorithm for the management of restless legs syndrome [published correction appears in Mayo Clin Proc. 2004;79(10):1341]. Mayo Clin Proc. 2004;79(7):916-922.
15. Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2006;19(5):487-493. (Pubitemid 44577207)
16. Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry. 2005;58(6):510-514.
17. Stiasny-Kolster K, Benes H, Peglau I, et al. Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology. 2004;63(12):2272- 2279. (Pubitemid 40024336)
18. Trenkwalder C, Hundemer HP, Lledo A, et al. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study. Neurology. 2004;62(8):1391-1397. (Pubitemid 38526054)
19. Silber MH, Girish M, Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study. Sleep. 2003;26(7):819-821. (Pubitemid 39610626)
20. Winkelman JW, Sethi KD, Kushida CA, et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology. 2006;67(6):1034-1039. (Pubitemid 44454599)
21. Oertel WH, Stiasny-Kolster K, Bergtholdt B, et al., for the Pramipexole RLS Study Group. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study). Mov Disord. 2007;22(2):213-219.
22. Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K, for the TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19(12):1414-1423.
23. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al., for the Therapy with Ropinirole, Efficacy and Tolerability in RLS 1 Study Group. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry. 2004;75(1):92-97.
24. Bogan RK, Fry JM, Schmidt MH, Carson SW, Ritchie SY, for the TREAT RLS US Study Group. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc. 2006;81(1):17-27.
25. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med. 2007;356(1):29-38. (Pubitemid 46041751)
26. Benes H, Kurella B, Kummer J, Kazenwadel J, Selzer R, Kohnen R. Rapid onset of action of levodopa in restless legs syndrome: a double- blind, randomized, multicenter, crossover trial. Sleep. 1999;22(8):1073-1081. (Pubitemid 30173982)
27. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep. 1996;19(3):205-213. (Pubitemid 26138225)
28. Winkelman JW, Johnston L. Augmentation and tolerance with longterm pramipexole treatment of restless legs syndrome (RLS). Sleep Med. 2004;5(1):9-14. (Pubitemid 38145706)
29. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 2002;59(10):1573-1579. (Pubitemid 35387065)
30. Happe S, Sauter C, Klösch G, Saletu B, Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology. 2003;48(2):82-86. (Pubitemid 37176872)
31. Walters AS, Wagner ML, Hening WA, et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep. 1993;16(4):327-332. (Pubitemid 23176289)
32. Kaplan PW, Allen RP, Buchholz DW, Walters JK. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep. 1993;16(8):717-723. (Pubitemid 24054963)
33. Lauerma H, Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry. 1999;60(4):241-244. (Pubitemid 29193922)